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OBJECTIVES The study was done to derive the optimum definition of complete revascularization in
coronary artery bypass surgery.
BACKGROUND “Complete revascularization” has been considered the goal of coronary artery bypass
operations, but various definitions of completeness exist.
METHODS We evaluated the Bypass Angioplasty Revascularization Investigation (BARI) surgical results
in the seven years after operation. Different definitions of completeness of revascularization
were retrospectively applied to the 1,507 patients in the combined randomized/registry group
to derive the definition of complete operative revascularization with the best discrimination
in long-term results between those with and without complete revascularization as defined.
Four definitions were evaluated: 1) traditional complete revascularization with one graft to
each major diseased artery system; 2) functional complete revascularization with one graft to
all diseased major or primary segmental vessels; 3) number of distal anastomoses greater than,
equal to or less than the number of diseased coronary segments; and 4) number of distal
anastomoses to the major coronary systems equal to 1 or greater than 1.
RESULTS No independent survival advantage existed for traditional or functional complete revascular-
ization as compared with incomplete revascularization. No survival advantage existed for any
of the three arms of definition 3. For definition 4, seven-year death/myocardial infarction was
highest (32.9%) when more than one anastomosis was constructed to any non-left anterior
descending coronary artery (LAD) system (relative risk 1.37, p 0.03). No increased risk was
associated with constructing more than one anastomosis into the LAD system.
CONCLUSIONS The construction of more than one graft to any system other than the LAD appears to confer
no long-term advantage, and may actually be deleterious. (J Am Coll Cardiol 2002;39:
565–72) © 2002 by the American College of Cardiology
“Complete revascularization” has achieved the stature of a
surgical mantra; its importance to superior long-term results
after coronary artery bypass operations has become accepted
as a truism. Indeed, numerous studies have demonstrated
the dichotomy in both survival and function between
patients receiving complete and incomplete revasculariza-
tion (1–14). However, prior studies have used different
definitions for complete or adequate revascularization.
Thus, a surgeon, deciding on a strategy for an individual
patient, has scant guidance from the literature as to which
specific arteries should be bypassed in order to achieve
complete revascularization. Unresolved are answers to such
questions as: “are more grafts always better than fewer?” and
“should each diseased branch of a major vessel be bypassed?”
Therefore, in this study, we sought to derive the definition
of optimal revascularization by starting with surgical results
and retrospectively applying various definitions of revascu-
larization completeness to an entire well-defined patient
population. We hypothesize that the definition(s) most
clearly separating patients with good long-term results from
those with lesser results could be applied prospectively by
surgeons contemplating the operative strategy to achieve
optimal revascularization.
METHODS
The Bypass Angioplasty Revascularization Investigation
(BARI) was designed as a multi-institutional study to
compare, in patients with multivessel coronary artery dis-
ease, the outcomes of patients initially assigned to percuta-
neous transluminal coronary angioplasty (PTCA) versus
coronary artery bypass graft (CABG) surgery (15). During a
three-year span beginning in August 1988, a total of 1,829
patients were enrolled in the randomized clinical trial.
During that same time, 2,010 patients who met all the
BARI randomization criteria were enrolled in the BARI
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registry because either they or their referring physicians
elected not to participate in the randomized trial. From
these patients, 901 patients in the randomized arm and 625
in the registry arm (total 1,526) received CABG surgery.
The BARI results at five and seven years have been analyzed
and reported, and further follow-up studies continue (16–
23).
The current investigation focuses only on these surgical
patients. Of these patients, 1,507 were evaluable; 19 were
excluded because of incomplete baseline angiographic or
initial surgical procedure data.
The BARI patient characteristics have been described
(15,24,25). Patients had multivessel coronary artery disease,
clinically severe angina or objective evidence of ischemia, a
need for revascularization, no prior coronary revasculariza-
tion and were suitable candidates for both PTCA and
CABG. Excluded were patients with left main stenosis
50% or primary coronary spasm.
Data collection. Baseline data collection included a demo-
graphic, clinical and angiographic profile, previous angina
history, electrocardiogram (ECG), medication use, func-
tional status and quality-of-life measures. Intraoperative
data collected included vessels bypassed, conduits used and
their configuration, adequacy of graft flow, distal vessel size,
reasons for intended vessels not bypassed, myocardial pro-
tection and anesthetic techniques and cardiopulmonary
bypass and cross-clamp times. Initial postsurgical data collec-
tion included postoperative (after hospital discharge) death,
myocardial infarction (MI), congestive heart failure (CHF),
hemorrhage, hypotension and cerebrovascular accident.
Throughout patient follow-up (mean 7.1 years), all hos-
pitalizations for intercurrent cardiovascular events were
carefully documented (including exact date) by use of
standard data collection forms and routine annual patient
contact. The ECGs were routinely collected throughout
follow-up and for all suspected MI events. A central ECG
laboratory coded all Q-wave events.
Angiographic definitions. The angiographic definitions
used in BARI have been described (26). Briefly, a significant
lesion was defined as a stenosis 50% diameter severity by
caliper measurement in a vessel with a reference diameter
1.5 mm. The vast majority of significant lesions identified
in BARI patients were in the proximal and mid-portions of
the major coronary arteries. In this report, we evaluated
surgical strategy using a four-vessel system consisting of the
right coronary artery (RCA), left anterior descending coro-
nary artery (LAD), left circumflex coronary artery (LCx)
and, if present, the ramus intermedius artery (Ramus). A
central radiologic laboratory interpreted angiograms from
patients in the randomized trial but not from those in the
observational registry. Therefore, clinical site readings were
used for all patients.
Definitions of completeness of revascularization. After
the surgical revascularization, different definitions of revas-
cularization completeness were individually applied to each
patient. By each of the definitions, patients were placed into
an analysis group of either complete or incomplete revascu-
larization. In essence, four new variables were created for
each patient. We considered four primary definitions of
complete revascularization (Table 1). Definition 1: “Tradi-
tional” complete revascularization was defined as all diseased
arterial systems (stenosis 50%) receiving at least one graft
insertion (83% of study population). Definition 2: “Func-
tional” complete revascularization was defined as bypassing
all diseased “primary” (Table 2) coronary segments (74% of
study population). Definition 3: Patients were grouped by
whether the number of distal anastomoses was less than
Abbreviations and Acronyms
BARI  Bypass Angioplasty Revascularization
Investigation
CABG  coronary artery bypass graft
CASS  Coronary Artery Surgery Study
CHF  congestive heart failure
ECG  electrocardiogram
IMA  internal mammary artery
LAD  left anterior descending coronary artery
LCx  left circumflex coronary artery
MI  myocardial infarction
PTCA  percutaneous transluminal coronary angioplasty
Ramus  ramus intermedius artery
RCA  right coronary artery
RR  relative risk
Table 1. Definitions of Extent of Revascularization
No. Definition Patient Subgroups n (%)
1 Traditional: all coronary arteries with at least one significant lesion receive
a graft
Complete revascularization 1,253 (83)
Incomplete revascularization 254 (17)
2 Functional: all diseased “primary” coronary segments are bypassed* Complete revascularization 1,114 (74)
Incomplete revascularization 393 (26)
3 Number of distal anastomoses are either less than, equal to or greater
than the number of diseased coronary segments
Distal sites  number of diseased segments 446 (30)
Distal sites  number of diseased segments 518 (34)
Distal sites  number of diseased segments 543 (36)
4 Number of distal anastomoses to the LAD or other coronary arteries 2 distal sites to LAD and to another artery 115 (8)
2 distal sites to LAD 426 (28)
2 distal sites to an artery other than LAD 216 (14)
2 distal sites to all arteries 750 (50)
*See Table 2 for explanation.
LAD  left anterior descending coronary artery.
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(30% of study population), equal to (34%) or greater than
(36%) the number of diseased coronary segments. Definition
4: Patients were grouped by whether they had 2 distal site
insertions to both the LAD and to a non-LAD arterial
system (8% of study population),2 distal sites to the LAD
(28%), 2 distal site insertions to a non-LAD arterial
system (14%) or by whether no arterial system had multiple
distal site insertions (50%).
We attempted to explore a fifth definition based on
specific segmental lesions compared to coronary grafts to
those specific segments. However, this proved not to be
feasible due to differential interpretation (misclassification)
of the boundaries of the 37 defined coronary segments
between the angiographers and the surgeons.
EXPLANATION OF TERMS IN PRECEDING DEFINITIONS.
Arterial system: Any of the four major arterial systems
consisting of LAD (including the diagonal), LCx, RCA and
Ramus. Segment: Any of the 29 segments of coronary
arteries as defined in the BARI study, and as shown in
Figure 1. Primary segment: Any of the following vessels:
RCA or its major branches of posterior descending coronary
artery and posterior atrioventricular segment; LAD or its
major diagonal branches; LCx or its major obtuse marginal
branches; and the Ramus. Diseased artery: Any artery of
1.5 mm with a diameter reduction of 50%.
Statistical analysis. For dichotomous definitions of the
extent of revascularization (definitions 1 and 2 in the
previous text), chi-square and the Student t tests were used
to compare differences in baseline angiographic character-
istics and initial in-hospital outcomes between patients with
and without complete revascularization; for initial in-
hospital outcomes between patients with and without com-
plete revascularization; for polychotomous definitions (def-
initions 3 and 4), chi-square tests and general linear models
were fit using a single between-group F test. The Kaplan-
Meier method (27) was used to calculate clinical event rates
over seven years of follow-up. Patients with incomplete
follow-up were censored at the last known date of follow-
up. The log-rank test (chi-square statistic) was used to
compare event-free survival curves over seven years between
subgroups of patients within each definition of revascular-
ization extent; a single main-effects test was used for each
definition. Seven-year clinical event rates were calculated
among all patients, and also after excluding the 23 operative
deaths from the analysis in order to assess the revascular-
ization strategy effect on late outcomes.
Clinical outcomes evaluated included death, cardiac
death, MI, need for repeat revascularization, angina pectoris
and the composite outcomes of death/MI and cardiac
death/MI. Separate Cox regression models (28) were fit to
assess the independent effect of each definition of revascu-
larization extent on clinical outcomes over seven-years of
follow-up, using a multistage stepwise algorithm. In the first
stage, the variables age, gender, race, number of significant
lesions, number of diffuse lesions and the use of an internal
mammary artery (IMA) graft were included (forced) as a
block in each model. In the second stage, 11 additional
baseline factors (history of CHF, MI, hypertension, treated
diabetes and renal dysfunction; current or past smoker;
unstable angina; number of class C lesions; peripheral
vascular disease; and left dominance) were allowed to “step”
into each model using a p value entry criterion of 0.10. In
the third stage, each one of the four revascularization
definitions was separately added to the model with the
variables from stages 1 and 2. Across all outcomes, the
maximum number of variables included in a model was 15,
and the minimum number of events (for cardiac death) was
70. All p values presented are two-sided.
RESULTS
Patient population. The mean age of the 1,507 patients at
study entry was 62  9 years; 26% were women and 92%
were white. In addition, 53% of the study population had a
prior history of MI, 65% presented with unstable angina,
19% had a history of treated diabetes and 8% had a history
of CHF. The mean ejection fraction was 61  13%.
Angiographic and procedural characteristics. Across the
first three definitions of the extent of revascularization,
patients who were incompletely revascularized had, on
average, more significant lesions than completely revascu-
larized patients (range 3.8 to 4.3 vs. 2.7 to 3.3), a higher
prevalence of three- or four-vessel disease (range 64% to
Table 2. Algorithm for “Functional” Revascularization
(Strategy 2) (Refer to Fig. 1)
Arterial
System Diseased Coronary Segment(s)
No. of Distal
Insertions
Required
RCA 1 only, 2 only, 3 only, 4 only, 5 only 1
RCA 1 and 2, 1 and 3, 2 and 3 1
RCA 1 and 4 or 5 2
RCA 2 and 4 or 5 2
RCA 3 and 4 or 5 2
RCA 6 or 7 or 8 or 9 or 10 0
LAD 12 only, 13 only, 14 only, 15 only, 16 only,
29 only
1
LAD 12 and 13, or 12 and 14, or 13 and 14 1
LAD 12 and 15 or 16 or 29 2
LAD 13 and 15 or 16 or 29 2
LAD 14 and 15 or 16 or 29 2
LAD 15a or 16a or 29a 0
LCx 18 only, 19 only, 19a only, 20 only, 21
only, 22 only
1
LCx 23 only (if left dominant) 1
LCx 18 and 19, or 18 and 19a, or 18 and 23 1
LCx 19 and 19a, or 19 and 23, or 19a and 23 1
LCx 18 and 20, 21, or 22 2
LCx 19 and 20, 21, or 22 2
LCx 19a and 20, 21, or 22 2
LCx 23 and 20, 21, or 22 2
LCx 20a or 21a or 22a or 24 or 25 or 26 or 27 0
Ramus 28 1
Ramus 28a 0
LAD  left anterior descending coronary artery; LCx  left circumflex coronary
artery; Ramus  ramus intermedius artery; RCA  right coronary artery.
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76% vs. 19% to 34%), fewer grafts placed (range 2.7 to 2.8
vs. 2.9 to 3.2) and fewer distal site insertions (range 2.9 to
3.1 vs. 3.3 to 3.6). For definition 4, patients with no more
than one distal site insertion to any vessel had, on average,
fewer significant lesions and a lower prevalence of three- or
four-vessel disease than patients with multiple distal site
insertions to a vessel.
In-hospital complications. Comparing subgroups of pa-
tients classified by the four definitions of the extent of
revascularization, the incidence of in-hospital complications
was similar among all subgroups (death: range 0.9% to
2.8%; Q-wave MI: range 3.6% to 6.1%; death/Q-wave MI:
range 4.7% to 8.0%; CHF or pulmonary edema: range 1.6%
to 5.1%).
Long-term outcome. DEFINITION 1. The incidence and
adjusted relative risks of all clinical outcomes over seven-
years of follow-up were similar between completely revas-
cularized and incompletely revascularized patients, although
the risk estimates were generally in the direction that
favored complete revascularization (Table 3).
DEFINITION 2. The incidence of mortality over seven-years
of follow-up was lower in patients with complete revascu-
larization than in those without (13.6% vs. 18.9%, Table 4);
this lower occurrence persisted after excluding the 23
patients who died in-hospital (12.5% vs. 16.8%). After
statistical adjustment, the lower risk of long-term mortality
associated with complete revascularization was attenuated
and no longer statistically significant, but it remained in the
direction of being protective.
DEFINITION 3. Both the incidence and the adjusted risk of
all clinical outcomes were similar among the three groups of
patients defined by the number of distal sites less than, equal
to or greater than the number of diseased segments (data
not shown). However, there was a nonsignificant suggestion
that patients with the number of distal sites equal to the
number of diseased segments had the most favorable long-
term outcome.
DEFINITION 4. The incidence of death, cardiac death and
MI over seven years was nonsignificantly higher in the two
subgroups of patients with multiple distal site insertions to
a non-LAD vessel (e.g., irrespective of whether there were
multiple LAD insertions) (Table 5). This trend of lower
long-term survival among patients with multiple distal site
insertions to a non-LAD vessel persisted after excluding the
23 patients who died in-hospital. When the combined
death/MI outcome was evaluated, the unadjusted and ad-
justed risks were significantly higher in the subgroup of
patients with multiple distal site insertions to a non-LAD
vessel and no more than one LAD graft insertion (Table 5).
Figure 1. The Bypass Angioplasty Revascularization Investigation coronary artery map. Right coronary artery: 1  proximal; 2  middle; 3  distal; 4 
posterior descending; 5 right posteroatrioventricular; 6 first posterolateral; 7 second posterolateral; 8 third posterolateral; 9 inferior septal artery;
10  acute marginal artery. Left coronary artery: 11  left main; 12  proximal left anterior descending; 13  middle left anterior descending; 14  distal
left anterior descending; 15 first diagonal; 15a first diagonal branch; 16 second diagonal; 16a second diagonal branch; 17 anterior septals; 18
proximal circumflex; 19  middle circumflex; 19a  distal circumflex; 20, 21, 22  first, second and third obtuse marginal; 20a, 21a, 22a  first, second
and third obtuse marginal branches; 23  left atrioventricular; 24, 25, 26  first, second and third posterolaterals; 27  left posterior descending; 28 
Ramus; 28a  Ramus branch; 29  third diagonal; 29a  third diagonal branch.
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Similar nonsignificant results were observed for the sub-
group of patients with multiple distal site insertions to both
the LAD and a non-LAD vessel. Overall, the adjusted risks
(death/MI, cardiac death/MI) associated with having mul-
tiple distal site insertions to a non-LAD vessel were on the
order of approximately 35% higher risk.
Thus, across the four definitions of the extent of revas-
cularization, the most evident finding was an apparent worse
long-term outcome associated with multiple distal site
insertions to a non-LAD vessel (definition 4).
Further investigation of patients with multiple anasto-
moses to a non-LAD system (definition 4). Among all
1,507 patients, a subgroup of 1,003 patients (67%) had no
more than one significant lesion (by the BARI definition) in
the LCx, RCA and Ramus systems. Unexpectedly, the
apparent lower survival associated with multiple distal anas-
tomoses to a non-LAD system was restricted to this
subgroup, as described in the following text.
The unadjusted survival rate over seven years was 81% for
the 148 patients who had multiple distal anastomoses to a
non-LAD system compared to 88% for the 855 patients
with no more than one graft insertion to a non-LAD system
(p  0.04). Freedom from death/MI over seven years in the
same subgroups was 68% and 77%, respectively (p  0.02).
Among the 148 patients with multiple distal anastomoses to
a non-LAD system (and overall poorer clinical outcome),
42% possessed one significant lesion and at least one
nonsignificant lesion in the non-LAD system that was
bypassed. An additional 46% of these 148 patients had only
one significant lesion and no recorded nonsignificant lesions
Table 3. Evaluation of Definition 1: Traditional Complete Revascularization
Seven-Year
Clinical Outcome†
Patient
Group
All Patients
(n  1,507)
Patients Without In-Hospital Death
(n  1,484)
Incidence
Adjusted
RR‡ 95% CI p Incidence
Adjusted
RR‡ 95% CI p
Death Incomplete 17.3 1.0 — — 15.0 1.0 — —
Complete 14.5 0.78 0.55, 1.11 0.17 13.4 0.84 0.58, 1.23 0.37
Cardiac death Incomplete 8.0 1.0 — — 5.8 1.0 — —
Complete 5.8 0.69 0.40, 1.17 0.17 4.9 0.84 0.45, 1.58 0.58
MI§ Incomplete 14.1 1.0 — — 13.8 1.0 — —
Complete 14.4 0.97 0.66, 1.42 0.86 14.4 0.99 0.67, 1.46 0.96
Death/MI Incomplete 25.8 1.0 — — 23.7 1.0 — —
Complete 25.8 0.92 0.69, 1.22 0.55 24.8 0.97 0.72, 1.30 0.83
Cardiac death/MI Incomplete 18.2 1.0 — — 16.2 1.0 — —
Complete 18.4 0.94 0.67, 1.32 0.73 17.6 1.03 0.72, 1.48 0.87
Repeat revascularization Incomplete 10.8 1.0 — — 10.5 1.0 — —
Complete 12.9 1.14 0.73, 1.78 0.55 12.9 1.19 0.76, 1.87 0.45
Angina during follow-up Incomplete 40.8 1.0 — — 42.0 1.0 — —
Complete 39.1 0.92 0.68, 1.24 0.58 39.6 0.89 0.66, 1.20 0.45
†In the Kaplan-Meier and Cox regression analyses, patients with incomplete follow-up were censored at the last known date of follow-up; censored patients do not contribute
to the estimation of clinical outcomes at seven years. ‡Per description in methods; owing to missing covariate data, as many as 22 cases were missing in the analysis. §Includes
both Q-wave and non–Q-wave infarctions. Excludes 51 surviving patients without reported angina status on at least 80% of the routinely scheduled follow-up forms.
CI  confidence interval; MI  myocardial infarction; RR  relative risk.
Table 4. Evaluation of Definition 2: Functional Complete Revascularization
Seven-Year
Clinical Outcome†
Patient
Group
All Patients
(n  1,507)
Patients Without In-Hospital Death
(n  1,484)
Incidence
Adjusted
RR‡ 95% CI p Incidence
Adjusted
RR‡ 95% CI p
Death Incomplete 18.9 1.0 — — 16.8 1.0 — —
Complete 13.6** 0.77 0.57, 1.05 0.10 12.5* 0.82 0.59, 1.14 0.24
Cardiac death Incomplete 7.6 1.0 — — 5.7 1.0 — —
Complete 5.7 0.81 0.49, 1.33 0.41 4.8 0.97 0.55, 1.71 0.91
MI§ Incomplete 14.2 1.0 — — 14.1 1.0 — —
Complete 14.4 1.06 0.75, 1.49 0.75 14.3 1.07 0.76, 1.51 0.70
Death/MI Incomplete 28.0 1.0 — — 26.1 1.0 — —
Complete 25.0 0.92 0.72, 1.17 0.50 24.1 0.96 0.74, 1.24 0.76
Cardiac death/MI Incomplete 18.7 1.0 — — 17.0 1.0 — —
Complete 18.3 1.01 0.74, 1.36 0.98 17.5 1.08 0.79, 1.47 0.65
Repeat revascularization Incomplete 13.1 1.0 — — 12.8 1.0 — —
Complete 12.4 0.92 0.63, 1.35 0.66 12.3 0.95 0.64, 1.39 0.78
Angina during follow-up Incomplete 38.1 1.0 — — 39.1 1.0 — —
Complete 39.8 1.06 0.81, 1.39 0.65 40.3 1.03 0.79, 1.36 0.81
†‡§See footnotes in Table 3. **p  0.01; *p  0.05.
Abbreviations as in Table 3.
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(50% stenosis) in the non-LAD system that received
multiple anastomoses. Finally, the remaining 12% of pa-
tients had nonsignificant disease only (no lesions 50%
stenosis) in the non-LAD system that received multiple
distal anastomoses.
DISCUSSION
No independent advantage existed from complete revascu-
larization by either the traditional (no. 1) or functional (no.
2) definitions, although the risk estimates were in the
direction that favored complete revascularization.
Contrary to our expectations, and perhaps to accepted
tenets of surgical coronary artery revascularization, we found
that increasing the number of anastomoses beyond one to
non-LAD arteries (definition 4) yielded apparently worse
rather than better long-term results. Two or more anasto-
moses into the RCA, circumflex or Ramus systems in-
creased the risk of death/MI over seven years in both the
entire patient population and among operative survivors,
and nonsignificantly increased the risk of MI and cardiac
death/MI. When the groups were subdivided by the num-
ber of distal stenoses in the arterial systems, the apparent
deleterious effect of more than one anastomosis into a
non-LAD arterial system was limited to patients with fewer
than two lesions (by the BARI definition) in each of these
systems.
These results raise two questions: First, are these findings
discrepant with published results of the benefits of complete
revascularization; and second, how can our results be ex-
plained?
Comparison with other studies. Numerous studies attest
to the value of complete revascularization, yet our study
shows no independent advantage to classically defined
complete revascularization as exemplified by definitions 1
and 2.
Studies by Bell in the Coronary Artery Surgery Study
(CASS), Bertelsen, Cukingnan, Tyras, Jones, Schaff, Cos-
grove, and Laurie all documented reduced long-term mor-
tality by the use of complete surgical revascularization
(1,2,4,5,11–14). Although these eight studies attest to the
advantage of complete revascularization, they all appear to
define that state as the revascularization of one vessel in each
of the three major coronary artery systems diseased, and
they do not necessarily advocate bypassing every stenotic
vessel, regardless of the number involved. Thus, there may
not be any functional difference between the strategy sug-
gested by these results and that suggested by the current
study.
Table 5. Evaluation of Definition 4: Number of Distal Sites to Different Vessels
Seven-Year
Clinical
Outcome† Patient Group
All Patients
(n  1,507)
Patients Without In-Hospital Death
(n  1,484)
Incidence
Adjusted
RR‡ 95% CI p Incidence
Adjusted
RR‡ 95% CI p
Death 2 sites to each vessel 14.4 1.0 — — 13.4 1.0 — —
2 sites to LAD and other vessel 14.2 1.13 0.65, 1.96 0.66 13.5 1.15 0.65, 2.03 0.64
2 sites to LAD, 2 to others 13.5 1.07 0.76, 1.49 0.70 11.4 0.95 0.66, 1.36 0.76
2 sites to non-LAD, 2 to LAD 20.3 1.26 0.87, 1.82 0.21 18.8 1.23 0.84, 1.80 0.30
Cardiac death 2 sites to each vessel 5.8 1.0 — — 5.0 1.0 — —
2 sites to LAD and other vessel 8.3 1.70 0.80, 3.64 0.17 8.3 2.17 0.99, 4.78 0.05
2 sites to LAD, 2 to others 5.7 1.18 0.70, 2.01 0.53 4.1 1.02 0.55, 1.89 0.94
2 sites to non-LAD, 2 to LAD 7.0 1.12 0.60, 2.08 0.71 5.3 0.95 0.46, 1.95 0.89
MI§ 2 sites to each vessel 13.2 1.0 — — 13.3 1.0 — —
2 sites to LAD and other vessel 15.2 1.29 0.75, 2.19 0.35 15.3 1.29 0.76, 2.21 0.34
2 sites to LAD, 2 to others 13.4 1.06 0.75, 1.50 0.75 13.3 1.04 0.74, 1.48 0.81
2 sites to non-LAD, 2 to LAD 19.7 1.44 0.99, 2.10 0.06 19.4 1.41 0.96, 2.06 0.08
Death/MI 2 sites to each vessel 24.3 1.0 — — 23.4 1.0 — —
2 sites to LAD and other vessel 26.4 1.27 0.84, 1.91 0.26 25.8 1.27 0.84, 1.91 0.26
2 sites to LAD, 2 to others 24.0 1.04 0.80, 1.35 0.78 22.2 1.04 0.80, 1.35 0.78
2 sites to non-LAD, 2 to LAD 34.2* 1.37 1.03, 1.83 0.03 32.9* 1.37 1.03, 1.83 0.03
Cardiac death/MI 2 sites to each vessel 17.1 1.0 — — 16.3 1.0 — —
2 sites to LAD and other vessel 20.7 1.37 0.86, 2.18 0.18 20.7 1.49 0.93, 2.38 0.09
2 sites to LAD, 2 to others 17.1 1.10 0.81, 1.49 0.54 15.7 1.05 0.77, 1.45 0.74
2 sites to non-LAD, 2 to LAD 24.2 1.39 0.99, 1.94 0.06 22.8 1.36 0.96, 1.93 0.08
Repeat revascularization 2 sites to each vessel 14.0 1.0 — — 14.0 1.0 — —
2 sites to LAD and other vessel 6.4 0.52 0.24, 1.15 0.11 6.4 0.52 0.24, 1.14 0.10
2 sites to LAD, 2 to others 10.7 0.82 0.56, 1.21 0.32 10.4 0.80 0.54, 1.18 0.25
2 sites to non-LAD, 2 to LAD 15.0 1.09 0.70, 1.69 0.71 14.6 1.04 0.66, 1.62 0.87
Angina during follow-up 2 sites to each vessel 40.9 1.0 — — 41.3 1.0 — —
2 sites to LAD and other vessel 39.8 1.09 0.71, 1.68 0.69 40.2 1.11 0.72, 1.71 0.64
2 sites to LAD, 2 to others 34.4 0.85 0.65, 1.11 0.23 35.3 0.87 0.67, 1.14 0.33
2 sites to non-LAD, 2 to LAD 43.4 1.11 0.80, 1.54 0.53 44.2 1.12 0.81, 1.56 0.49
†‡§See footnotes in Table 3. *p  0.05 for single comparison among all four groups.
LAD  left anterior descending coronary artery, other abbreviations as in Table 3.
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Interpretation of the results. We found no independent
survival advantage or disadvantage to what we defined as
“traditional” complete revascularization in which every ar-
terial system containing a stenosis was bypassed. In fact,
these data suggest an apparent survival disadvantage of
placing more than one graft in any system other than the
LAD. Based on studies such as those cited in the previous
text, we believe that surgeons have almost universally, and
perhaps even logically, concluded that no stenoses in vessels
of bypassable size should be left un-bypassed. We also
realize that advice to the contrary may be viewed as
heretical. But in retrospect, the studies cited above appear to
advocate a strategy that may be no different from the one
suggested by our data, although none of them specifically
examined the possible disadvantage of adding extra grafts as
we did.
Because we found that the apparent disadvantage of
multiple grafts into any non-LAD system was confined to
those patients with 2 diseased segmental branches in each
of those systems, the obvious and immediate question to be
asked is: “why would any surgeon choose to graft nondis-
eased vessels?” In the present study, about 15% of patients in
whom multiple grafts were performed into a non-LAD
system fell into that category. The primary explanation for
what might seem to be illogical surgical judgment is that the
vessel disease severity analysis was performed by the cathe-
terization laboratory personnel at each site, not by the
surgeons. A vessel was considered nondiseased if it was
1.5 mm in diameter by caliper measurement regardless of
the degree of stenosis, or with a stenosis of 50%. As
previously mentioned, 42% of these patients had, by angio-
graphic assessment, one significant and one nonsignificant
lesion in the non-LAD system bypassed, 46% had only one
lesion, and 12% had no significant lesions. But many of
these same vessels were thought to have sufficient disease
and to be of sufficient size by the surgeons to warrant
multiple graft insertions. Vessels with no disease were not
bypassed.
The finding that more than one graft to a non-LAD
system was associated with higher seven-year death/MI
could be explained with the criticism that the additional
grafts did not cause the worse results, but instead were a
marker for more extensive disease that contributed to the
increased late mortality. However, the number of significant
lesions and the number of diffuse lesions were included as
covariates in the multivariable models and individually were
not associated with seven-year mortality (relative risk [RR]
 1.08, p  0.14; RR  1.04, p  0.56, respectively).
Furthermore, the finding of higher death/MI with multiple
grafts to a non-LAD system was present after statistical
adjustment for prognostic baseline variables and use of an
IMA graft. Thus, our data indicate a possible independent
adverse effect associated with inserting multiple grafts to a
non-LAD system and, almost certainly, no advantage asso-
ciated with such a strategy.
Study limitations. Our results and conclusions are based
on BARI patients, all of whom had multivessel disease.
However, because all BARI patients were required to be
clinically suitable for PTCA, patients with the most severe
and extensive disease were deemed ineligible for study
inclusion. Hence, our study probably included fewer pa-
tients with complex and severe coronary stenoses than were
present in other medical/surgical studies such as CASS. A
second criticism, and one difficult to gainsay, is that those
patients who had more than one graft insertion to a
non-LAD system possibly had grafts constructed to vessels
of size sufficiently small to predispose to a higher graft
occlusion rate. Because late follow-up angiography was not
routinely performed in BARI, we were unable to investigate
the plausibility of this criticism. Finally, there may be some
unmeasured confounding variables that could contribute to
the apparent worse outcomes associated with multiple grafts
to a non-LAD system.
Conclusions. We conclude that, in the population studied,
regardless of the extent of distal disease, inserting more than
one graft into the RCA, LCx or Ramus systems may not be
warranted and may, in fact, increase the long-term risk of
death/MI as compared with inserting no more than one
graft to each of these vessels. In contrast, placement of more
than one graft in the LAD system, when indicated by
disease in more than one segmental branch, does not
adversely influence long-term patient prognosis.
In summary, we recommend considering that no more
than one graft need be performed into a non-LAD system,
regardless of the number of diseased vessel segments, with
the consequence of the contrary strategy being results that
are no better, and perhaps worse. Conversely, two or more
grafts may be considered in the LAD under appropriate
anatomical circumstances, such as when more than two
large branches are stenotic.
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